CHLORAMPHENICOL; PREDNISOLONE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for chloramphenicol; prednisolone and what is the scope of patent protection?
Chloramphenicol; prednisolone
is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for CHLORAMPHENICOL; PREDNISOLONE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 1 |
DailyMed Link: | CHLORAMPHENICOL; PREDNISOLONE at DailyMed |
Recent Clinical Trials for CHLORAMPHENICOL; PREDNISOLONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
US Patents and Regulatory Information for CHLORAMPHENICOL; PREDNISOLONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | CHLOROPTIC-P S.O.P. | chloramphenicol; prednisolone | OINTMENT;OPHTHALMIC | 061188-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |